This bill repeals the tax on Social Security benefits for seniors, making those benefits fully tax-free. It directly affects seniors who receive Social Security benefits and are currently subject to income tax on a portion of those payments. The key provision removes Section 86 of the tax code that previously included benefits in gross income, while a separate funding mechanism appropriates money to Social Security trust funds to replace the lost revenue. The bill ensures Social Security trust funds remain fully funded without requiring new tax increases.
HR 3086, the "Find It Early Act," requires health insurance plans to cover breast cancer screenings with no cost-sharing for certain individuals at higher risk of breast cancer. The bill affects people with increased risk (based on medical criteria or dense breast tissue) or those needing screening due to factors like age, race, ethnicity, or family history. Key provisions mandate coverage for 2D/3D mammograms, ultrasounds, MRI, and other technologies without frequency limits for these groups. This applies to group health plans, Medicare, Medicaid, TRICARE, and VA healthcare systems starting January 1, 2024. The law aims to improve early detection by removing financial barriers to necessary screenings.
This bill changes tax rules to treat direct primary care (DPC) membership fees as deductible medical expenses. It defines DPC as a fixed monthly fee (capped at $150 per person, $300 for families) for primary care services only, excluding procedures requiring anesthesia, prescription drugs (except vaccines), or lab tests. The law ensures these fees can be claimed on tax returns like other medical costs, while clarifying DPC arrangements aren’t considered health insurance plans. It applies to fees paid for DPC services provided through employment or directly to patients, effective for 2024 tax years.
This bill creates a new tax deduction for healthcare providers who offer free medical care to eligible patients. It allows direct primary care physicians (those charging a subscription fee) to deduct the published fees for free care provided, plus half the subscription fee per visit. Other providers can deduct the Medicare-reimbursed value of free care given to patients enrolled in Medicaid or children's health programs. The deduction is limited to the provider's total income from medical services that year. It directly affects healthcare providers who offer free care to Medicaid/Medicare-eligible patients without expecting payment.
This bill regulates pharmacy benefit managers (PBMs) working with Medicare Part D prescription drug plans. It prohibits PBMs from earning income based on drug prices or rebates (requiring flat fees instead), mandates equal reimbursement for all network pharmacies, and requires PBMs to report how much of drug rebates they pass through to Medicare plans. The law also mandates annual compliance certifications and requires the government to publish aggregated transparency data (without revealing specific plan details) starting in 2024. These changes directly affect Medicare Part D plans and the seniors who rely on them for prescription drug coverage.
HR 2774, the Accelerating Individuals into the Workforce Act, creates federal grants for states to run demonstration projects providing wage subsidies to help Temporary Assistance for Needy Families (TANF) recipients and low-income adults (unemployed or earning under 200% of the federal poverty line) enter and keep jobs. States must design subsidy programs covering up to 50% of wages for up to 12 months per participant, while ensuring no job displacement and coordinating with other workforce programs. The bill requires states to report monthly on participants, retention rates in unsubsidized jobs after 2-4 quarters, and median earnings, and mandates a rigorous federal evaluation using randomized trials or strong research methods. Funds are reserved at $100 million for fiscal year 2023, with implementation starting October 1, 2023.
HR 2707, the MADE in America Act, creates a 25-30% federal tax credit for manufacturers producing specific health products (including drugs, medical devices, personal protective equipment, and diagnostic tools) in designated "distressed zones." These zones are census tracts with over 30% poverty rates that are also designated as qualified opportunity zones. The credit applies to wages paid to employees working in these zones and qualified production costs (like equipment and materials), increasing to 30% if most employees reside locally. It directly affects pharmaceutical and medical device manufacturers operating in eligible low-income areas, aiming to incentivize domestic production of critical health products.
HR 2667, the "Fighting Trade Cheats Act of 2023," increases penalties for importers who commit customs fraud or gross negligence. It triples civil penalties for fraudulent violations (to three times the domestic value) and raises gross negligence penalties to ten times, while adding five-year import bans for fraud and two-year bans for gross negligence. The bill also allows U.S. businesses, unions, or trade groups harmed by such violations to sue violators in federal court for triple damages, attorney fees, and injunctions against further imports. Additionally, it excludes violators and their affiliated companies from the Importer of Record program, with special rules to block shell companies evading customs laws. This directly affects importers who violate customs laws and U.S. businesses competing with those imports.
This bill would require Medicare to cover FDA-approved blood tests that screen for multiple cancers simultaneously (like breast, lung, or colorectal cancer) for beneficiaries. It directly affects Medicare recipients aged 65+ who could access these new screenings once per year, without prior authorization. The key provision adds "multi-cancer early detection screening tests" to Medicare's covered services under Part B, defining them as blood tests analyzing cell-free DNA, while maintaining existing coverage for standard screenings like mammograms. The bill does not change current coverage for individual cancer screenings but ensures Medicare keeps pace with new medical technology.
HR 1755 allows the U.S. President to grant Uzbekistan permanent normal trade relations (NTR) status, removing special tariffs on Uzbek exports entering the U.S. market. It terminates the requirement for annual U.S. reviews of Uzbekistan's trade status under a 1974 law. The change takes effect only after Uzbekistan joins the World Trade Organization (WTO). This directly affects Uzbekistan's exporters by enabling their goods to enter the U.S. under standard tariff rates.
This bill expands Medicare Part B coverage to include specific pharmacist services, directly affecting Medicare beneficiaries and pharmacists who provide these services. It adds new coverage for pharmacist evaluations and treatments related to certain illnesses (like COVID-19, flu, or strep throat) and public health emergencies, requiring payment at 80% of the lesser of actual charge or 85% of physician payment rates (100% during emergencies). The bill also prohibits balance billing for these services, ensuring beneficiaries pay only the standard Medicare copayment. These changes aim to improve access to pharmacist care during health crises while aligning payment with existing physician service frameworks.
The Emergency Care Improvement Act would permanently allow freestanding emergency centers (FECs) to receive Medicare and Medicaid reimbursement for emergency services. FECs are independently licensed facilities operating 24/7 with on-site physicians, providing emergency care equivalent to hospital-based emergency rooms. The bill sets payment rates for FECs equal to hospital outpatient department rates for higher-level emergency services, based on existing Medicare payment structures. This change would apply to over 110 FECs, mostly in Texas, which previously operated under a temporary pandemic waiver and demonstrated 21.8% cost savings to Medicare for similar care.
